SCHEMBL17034980

SCHEMBL17034980

O=P(c1ccccc1)(c1ccccc1)c1cccc(-c2ccc3cc(-c4cc5c(-c6ccccc6)nc6ccccc6c5c5ccccc45)ccc3c2)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 6/20 0.36
TOP1 P11387 1/20 0.35
ADORA2A P29274 2/20 0.33
ACACA Q13085 2/20 0.33
NUDT1 P36639 1/20 0.33
ADORA1 P30542 1/20 0.33
PDE10A Q9Y233 2/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
TSHR P16473 1/20 0.32
BACE1 P56817 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034978 0.95 DHODH (0.38) DHODHTOP1ADORA2AACACANUDT1
SCHEMBL18200769 0.95 ADORA2A (0.34) DHODHTOP1ADORA2AACACAADORA1
SCHEMBL17034970 0.94 DHODH (0.37) DHODHTOP1ADORA2ANUDT1PDE10A
SCHEMBL18346972 0.93 TOP1 (0.36) DHODHTOP1ADORA2AACACAADORA1
SCHEMBL18346971 0.91 ADORA2A (0.36) DHODHTOP1ADORA2AACACAADORA1
SCHEMBL18201314 0.89 TOP1 (0.35) DHODHTOP1ADORA2AACACANUDT1
SCHEMBL17034887 0.88 DHODH (0.41) DHODHTOP1ADORA2AACACANUDT1
SCHEMBL17034974 0.88 DHODH (0.41) DHODHTOP1ADORA2AACACANUDT1
SCHEMBL20967906 0.88 TOP1 (0.41) DHODHTOP1ADORA2A
SCHEMBL18200991 0.86 DHODH (0.36) DHODHTOP1ADORA2AACACAADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 DHODH 2312/4885TOP1 616/4885ADORA2A 4650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.